Effect of Variant Alleles SLCO1B1 and ABCG2 on Pharmacokinetics of Rosuvastatin in Healthy Volunteers

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONC-10001058

Enrollment

Unknown

Registered

2010-10-20

Start date

2010-10-30

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperlipemia

Interventions

1:collect blood sample

Eligibility

Sex/Gender

All

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. The age of the subjects ranged from 18 to 40; 2. The subjects were in excellenthealth with no clinically relevant conditions identified from medical history, physical examinations, electrocardiogram, blood chemistry, hematology,and urine analysis.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Pharmacokinetic parameter;	—

Countries

China

Contacts

Public ContactHongHao Zhou

hhzhou2003@163.com+86 731 84805380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026